Accelerate Diagnostics, Inc. (AXDX): Price and Financial Metrics


Accelerate Diagnostics, Inc. (AXDX): $0.61

-0.08 (-11.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AXDX POWR Grades


  • Growth is the dimension where AXDX ranks best; there it ranks ahead of 81.96% of US stocks.
  • AXDX's strongest trending metric is Value; it's been moving up over the last 179 days.
  • AXDX's current lowest rank is in the Momentum metric (where it is better than 5.5% of US stocks).

AXDX Stock Summary

  • Accelerate Diagnostics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 5.03% of US listed stocks.
  • AXDX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.35% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AXDX comes in at -44.31% -- higher than that of only 9.69% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Accelerate Diagnostics Inc are COUP, QNST, PLUG, UCL, and QLYS.
  • AXDX's SEC filings can be seen here. And to visit Accelerate Diagnostics Inc's official web site, go to acceleratediagnostics.com.

AXDX Valuation Summary

  • AXDX's EV/EBIT ratio is -7.4; this is 125.26% lower than that of the median Healthcare stock.
  • AXDX's EV/EBIT ratio has moved down 1.9 over the prior 243 months.
  • Over the past 243 months, AXDX's price/sales ratio has gone up 16.5.

Below are key valuation metrics over time for AXDX.

Stock Date P/S P/B P/E EV/EBIT
AXDX 2021-08-31 32.0 -5.5 -4.6 -7.4
AXDX 2021-08-30 31.8 -5.5 -4.6 -7.3
AXDX 2021-08-27 31.9 -5.5 -4.6 -7.4
AXDX 2021-08-26 31.0 -5.3 -4.5 -7.2
AXDX 2021-08-25 32.1 -5.5 -4.6 -7.4
AXDX 2021-08-24 33.3 -5.7 -4.8 -7.6

AXDX Growth Metrics

    Its 4 year net cashflow from operations growth rate is now at -52.02%.
  • Its 4 year price growth rate is now at -10.78%.
  • The 5 year revenue growth rate now stands at 3240.88%.
Over the past 52 months, AXDX's revenue has gone up $9,686,000.

The table below shows AXDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 11.782 -47.323 -77.702
2021-09-30 11.547 -45.719 -73.811
2021-06-30 12.013 -45.927 -83.582
2021-03-31 11.34 -46.172 -81.138
2020-12-31 11.165 -50.394 -78.208
2020-09-30 11.525 -53.916 -80.631

AXDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AXDX has a Quality Grade of D, ranking ahead of 23.75% of graded US stocks.
  • AXDX's asset turnover comes in at 0.125 -- ranking 68th of 75 Measuring and Control Equipment stocks.
  • AATC, TMO, and BMI are the stocks whose asset turnover ratios are most correlated with AXDX.

The table below shows AXDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.125 0.366 -0.333
2021-03-31 0.112 0.379 -0.320
2020-12-31 0.103 0.399 -0.302
2020-09-30 0.097 0.418 -0.316
2020-06-30 0.079 0.458 -0.343
2020-03-31 0.071 0.467 -0.358

AXDX Price Target

For more insight on analysts targets of AXDX, see our AXDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.00 Average Broker Recommendation 1.7 (Moderate Buy)

AXDX Stock Price Chart Interactive Chart >

Price chart for AXDX

AXDX Price/Volume Stats

Current price $0.61 52-week high $9.36
Prev. close $0.69 52-week low $0.61
Day low $0.61 Volume 593,000
Day high $0.83 Avg. volume 431,894
50-day MA $1.29 Dividend yield N/A
200-day MA $4.15 Market Cap 42.49M

Accelerate Diagnostics, Inc. (AXDX) Company Bio


Accelerate Diagnostics is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company was founded in 1982 and is based in Tucson, Arizona.


AXDX Latest News Stream


Event/Time News Detail
Loading, please wait...

AXDX Latest Social Stream


Loading social stream, please wait...

View Full AXDX Social Stream

Latest AXDX News From Around the Web

Below are the latest news stories about Accelerate Diagnostics Inc that investors may wish to consider to help them evaluate AXDX as an investment opportunity.

Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 8, 2022, at 4:30 p.m. Eastern Time to review 2021 fourth quarter and full year financial results.

Yahoo | February 24, 2022

Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 15, 2022

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 10, 2022

Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time.

Yahoo | February 2, 2022

What Is The Ownership Structure Like For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Every investor in Accelerate Diagnostics, Inc. ( NASDAQ:AXDX ) should be aware of the most powerful shareholder groups...

Yahoo | January 31, 2022

Read More 'AXDX' Stories Here

AXDX Price Returns

1-mo N/A
3-mo -77.15%
6-mo -88.40%
1-year -91.22%
3-year -96.84%
5-year -97.82%
YTD -88.31%
2021 -31.13%
2020 -55.15%
2019 46.96%
2018 -56.11%
2017 26.27%

Continue Researching AXDX

Want to see what other sources are saying about Accelerate Diagnostics Inc's financials and stock price? Try the links below:

Accelerate Diagnostics Inc (AXDX) Stock Price | Nasdaq
Accelerate Diagnostics Inc (AXDX) Stock Quote, History and News - Yahoo Finance
Accelerate Diagnostics Inc (AXDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7983 seconds.